Download PDF
Thromb Haemost 1988; 59(02): 162-163
DOI: 10.1055/s-0038-1642746
Original Articles
Schattauer GmbH Stuttgart

Time Dependence of Whole Blood Aggregation in Response to Platelet Activating Factor (PAF)

R R Taylor
The Departments of Medicine and Cardiology, University of Western Australia and Royal Perth Hospital, Western Australia
,
J Strophair
The Departments of Medicine and Cardiology, University of Western Australia and Royal Perth Hospital, Western Australia
,
M Sturm
The Departments of Medicine and Cardiology, University of Western Australia and Royal Perth Hospital, Western Australia
,
R Vandongen
The Departments of Medicine and Cardiology, University of Western Australia and Royal Perth Hospital, Western Australia
,
L J Beilin
The Departments of Medicine and Cardiology, University of Western Australia and Royal Perth Hospital, Western Australia
› Author Affiliations
Further Information

Publication History

Received 16 June 1987

Accepted after revision 30 October 1987

Publication Date:
31 May 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

The aggregation/adhesion response to platelet activating factor (PAF) was studied in diluted whole blood by impedance aggregometry. The extent of aggregation varied directly with the interval between blood sampling and aggregation measurement over the first 30 minutes from sampling, then remained stable for the next 60 minutes of observation. This is an effect opposite to that described for aggregation to PAF in platelet rich plasma which, however, cannot be studied soon after sampling. Time dependence of aggregation is important and comparative measurements should be made during the period of stable aggregability.

Keywords

Platelet aggregation - Platelet activating factor
 

  • References

  • 1 McManus LM, Hanahan DJ, Pinckard RN. Human platelet stimulation by acetyl glyceryl ether phosphorylcholine. J Clin Invest 1981; 67: 903-906
    CrossrefPubMedGoogle Scholar
  • 2 Kloprogge E, de Haas GH, Gorter G, Akkerman JW N. Properties of PAF-acether-induced platelet aggregation and secretion. Studies in gel-filtered human platelets Thromb Res 1983; 29: 595-608
    CrossrefPubMedGoogle Scholar
  • 3 Lecrubier C, Conard J, Horellou MH, Samama M. Study of platelet aggregation induced by platelet activating factor (PAF) after administration of ticlopidine or aspirin. Agents actions 1983; 13: 77-80
    CrossrefPubMedGoogle Scholar
  • 4 Fouque F, Vargaftig BB. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation. Br J Pharmac 1984; 83: 625-633
    CrossrefPubMedGoogle Scholar
  • 5 Russell-Smith NC, Flower RJ, Cardinal DC. Measuring platelet and leucocyte aggregation/adhesion responses in very small volumes of whole blood. J Pharmacol Meth 1981; 6: 315-333
    CrossrefPubMedGoogle Scholar
  • 6 Riess H, Braun G, Brehm G, Hiller E. Critical evaluation of platelet aggregation in whole human blood. Am J Clin Pathol 1986; 85: 50-56
    CrossrefPubMedGoogle Scholar
  • 7 Abbate R, Favilla S, Boddi M, Costanzo G, Prisco D. Factors influencing platelet aggregation in whole blood. Am J Clin Pathol 1986; 86: 91-96
    CrossrefPubMedGoogle Scholar
  • 8 Taylor RR, Sturm M, Vandongen R, Strophair J, Beilin LJ. Whole blood platelet aggregation is not affected by cigarette smoking but is sex related. Clin Exp Pharmacol Physiol 1987; 665-671
    PubMedGoogle Scholar
  • 9 Kloprogge E, Hasselaar P, Gorter G, Akkerman JW N. Stimulus-aggregation coupling in platelets activated with PAF-axcether. Biochim Biophys Acta 1986; 883: 127-137
    CrossrefPubMedGoogle Scholar
  • 10 Bevan J, Heptinstall S, Knox A, Vathenen AS, Tattersfield AE. PAF-induced platelet aggregation in whole blood and the effect of administering BN52063 to man (Abstract). In: The role of plateletactivating factor in the immune response. Fondation IPSEN pour la Recherche Therapeutique; Paris: 1987
    Google Scholar